Corcept Therapeutics Inc (NASDAQ: CORT) kicked off on Monday, down -4.14% from the previous trading day, before settling in for the closing price of $33.31. Over the past 52 weeks, CORT has traded in a range of $20.84-$35.22.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 14.14%. While this was happening, its average annual earnings per share was recorded 2.39%. With a float of $89.70 million, this company’s outstanding shares have now reached $103.41 million.
Let’s determine the extent of company efficiency that accounts for 352 employees.
Corcept Therapeutics Inc (CORT) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Corcept Therapeutics Inc is 13.85%, while institutional ownership is 88.42%. The most recent insider transaction that took place on Jun 03 ’24, was worth 320,000. In this transaction Chief Development Officer of this company sold 10,000 shares at a rate of $32.00, taking the stock ownership to the 6,039 shares. Before that another transaction happened on Jun 03 ’24, when Company’s insider sold 5,000 for $30.18, making the entire transaction worth $150,916. This insider now owns 7,314 shares in total.
Corcept Therapeutics Inc (CORT) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 2.39% per share during the next fiscal year.
Corcept Therapeutics Inc (NASDAQ: CORT) Trading Performance Indicators
Take a look at Corcept Therapeutics Inc’s (CORT) current performance indicators. Last quarter, stock had a quick ratio of 5.10. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.35. Likewise, its price to free cash flow for the trailing twelve months is 26.66.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.06, a number that is poised to hit 0.23 in the next quarter and is forecasted to reach 1.35 in one year’s time.
Technical Analysis of Corcept Therapeutics Inc (CORT)
Looking closely at Corcept Therapeutics Inc (NASDAQ: CORT), its last 5-days average volume was 1.13 million, which is a drop from its year-to-date volume of 1.4 million. As of the previous 9 days, the stock’s Stochastic %D was 66.87%. Additionally, its Average True Range was 1.66.
During the past 100 days, Corcept Therapeutics Inc’s (CORT) raw stochastic average was set at 77.12%, which indicates a significant increase from 58.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 72.84% in the past 14 days, which was higher than the 48.17% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $26.53, while its 200-day Moving Average is $26.70. However, in the short run, Corcept Therapeutics Inc’s stock first resistance to watch stands at $32.60. Second resistance stands at $33.26. The third major resistance level sits at $34.48. If the price goes on to break the first support level at $30.71, it is likely to go to the next support level at $29.49. Now, if the price goes above the second support level, the third support stands at $28.83.
Corcept Therapeutics Inc (NASDAQ: CORT) Key Stats
The company with the Market Capitalisation of 3.32 billion has total of 104,110K Shares Outstanding. Its annual sales at the moment are 482,380 K in contrast with the sum of 106,140 K annual income. Company’s last quarter sales were recorded 146,810 K and last quarter income was 27,760 K.
